Genvor Incorporated
GNVR
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.26M | 2.61M | 3.42M | 3.04M | 2.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 38.80K | 38.80K | 38.80K | 38.80K | -- |
| Total Operating Expenses | 6.48M | 2.78M | 3.65M | 3.22M | 2.63M |
| Operating Income | -6.48M | -2.78M | -3.65M | -3.22M | -2.63M |
| Income Before Tax | -6.53M | -2.89M | -3.82M | -3.43M | -2.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.53 | -2.89 | -3.82 | -3.43 | -2.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.53M | -2.89M | -3.82M | -3.43M | -2.88M |
| EBIT | -6.48M | -2.78M | -3.65M | -3.22M | -2.63M |
| EBITDA | -6.47M | -2.78M | -3.64M | -3.22M | -2.63M |
| EPS Basic | -0.32 | -0.15 | -0.20 | -0.18 | -0.15 |
| Normalized Basic EPS | -0.20 | -0.09 | -0.12 | -0.10 | -0.09 |
| EPS Diluted | -0.32 | -0.15 | -0.20 | -0.18 | -0.15 |
| Normalized Diluted EPS | -0.20 | -0.09 | -0.12 | -0.10 | -0.09 |
| Average Basic Shares Outstanding | 80.80M | 79.55M | 78.09M | 76.37M | 75.08M |
| Average Diluted Shares Outstanding | 80.80M | 79.55M | 78.09M | 76.37M | 75.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |